51: Unraveling The Complexity Of Commercializing Cell And Gene Therapies W/ Wajiha Ali - Part 1 Smart Biotech Scientist | Master Bioprocess CMC Development, Biologics Manufacturing & Scale-up For Busy Scientists podcast

Are you finding the path to commercializing cell and gene therapies complex and uncertain?

Join us as we explore this intricate landscape with our guest, Wajiha Ali. As a strategy expert who believes in bridging the gap between research and commericalization with data who she will guide us through the challenges, victories, and vital strategies for successfully bringing these cutting-edge therapies to market.

Key Highlights:

Discover the amplified complexity of cell and gene therapies, from patient referral hurdles to manufacturing site regulations.
Explore the crucial commercialization strategies, infrastructure requirements, and the delicate balance between innovation and necessity.
Unveil the regulatory scrutiny and stakeholder management intricacies, paving the way for safer, more accessible therapies.

Tune in as we navigate the journey from scientific breakthroughs to real-world application, unraveling the complexities shaping the future of healthcare.

Connect with Wajiha Ali:

LinkedIn: https://www.linkedin.com/in/wajiha-ali-6468454

X (Twitter): https://twitter.com/Wajihaali

Next Step:

Develop biologics and cell & gene therapies with peace of mind. Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment